Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that it enclosed a Press Release on 16th September 2021 titled ‘National Company Law Tribunal approves scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd’.
The above information is a part of company’s filings submitted to BSE.